Turn Therapeutics' IPO

Listed Oct 8, 2025 by a direct listing on Nasdaq as TTRX, with no offer price.

Ticker

TTRX

Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

From its final prospectus (424B4) on SEC EDGAR, filed Oct 8, 2025.

What does Turn Therapeutics do?

“We are a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance.”

From its final prospectus (424B4), filed Oct 8, 2025

What is the offering?

Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.

Turn Therapeutics' facts, each with its source
Fact	Turn Therapeutics
Exchange	Nasdaq, as TTRX (applied to list)From the final prospectus (424B4) filed Oct 8, 2025

What the filing says about its money

Turn Therapeutics' facts, each with its source
Fact	Turn Therapeutics
Net loss	$1.8 million, year to December 31, 2024From its final prospectus (424B4) of Oct 8, 2025, its summary financial data

What risks does Turn Therapeutics name first?

“We design, develop, and conduct pre-clinical and clinical testing on drug candidates and medical devices.”
“We have a limited operating history and there are inherent uncertainties and risks in pharmaceutical and medical device product development and commercialization.”
“If we fail to obtain or generate the capital necessary to fund our operations, we will be unable to continue or complete our product development and you will likely lose your entire investment.”

The first three of the risks its prospectus summary lists, in the company's words. The rest, and each in full, are in the filing. Read the filing.

Every date of Turn Therapeutics' IPO

Turn Therapeutics' IPO dates, each with its source
What	Day	Source
Registration filedForm S-1, SEC EDGAR	Sep 2, 2025	Form S-1, SEC EDGAR
Exchange registration filedexchange registration (Form 8-A), SEC EDGAR	Sep 29, 2025	exchange registration (Form 8-A), SEC EDGAR
Pricedfinal prospectus (424B4), SEC EDGAR	Oct 8, 2025	final prospectus (424B4), SEC EDGAR
First tradeMassive's IPO calendar	Oct 8, 2025	Massive's IPO calendar
Declared effective by the SECSEC notice of effectiveness, SEC EDGAR	Apr 2, 2026	SEC notice of effectiveness, SEC EDGAR
Lock-upNo lock-up period read from its prospectus	Not read	No lock-up period read from its prospectus

How did its first days trade?

From its daily bars, each close against its $5.83 offer price.

Turn Therapeutics' first sessions
Day	Open	Close	From the offer
Oct 8	$10	$7	+20.1%
Oct 9	$24.71	$9.20	+57.8%
Oct 10	$8.25	$7.45	+27.8%
Oct 13	$7.19	$6.51	+11.7%
Oct 14	$6.20	$5.97	+2.4%

The other IPOs expected

The other IPOs expected or in registration
Company	Price	Market cap	Expected
OPAYNYSE: OPAY · No day yet	$19 to $21	Not yet	No day yetexchange registration Oct 26
Georgia BankingNasdaq: GBC · No day yet	Direct	Not yet	No day yetexchange registration Oct 21
Aspen NeuroscienceNasdaq: ASPE · No day yet	$15 to $17About $465M	$465Mat the midpoint	No day yetterms set Oct 26
Bambusa TherapeuticsNasdaq: BBTX · No day yet	$15 to $17About $796M	$796Mat the midpoint	No day yetterms set Oct 26
BitariNasdaq: BIAI · No day yet	$7About $302M	$302Mat the midpoint	No day yetterms set Oct 26
LIS TechnologiesNasdaq · No day yet	$5 to $7	Not yet	No day yetterms set Oct 26

Turn Therapeutics IPO questions

When is Turn Therapeutics' IPO?

Listed Oct 8, 2025 by a direct listing on Nasdaq as TTRX, with no offer price.

What is Turn Therapeutics' IPO price?

Turn Therapeutics lists directly: there is no offer price, and its first price is set by the exchange's opening auction.

Does Breakaway rate Turn Therapeutics?

Breakaway scores a new stock from its second trading day, ranked against every US stock it scores. For its first 21 sessions the page says New listing in place of the tier, and each check that needs more history waits for it.

Can Breakaway say where Turn Therapeutics' price will go?

No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.

Where every figure comes from.

Each company's SEC filings on EDGAR, read twice a day: its registration (Form S-1 or F-1), the amendment that sets its price range, and its final prospectus (424B4). The shares, the price, the underwriters, the lock-up, and the company's words are the filing's, linked on each line.
The expected day is Massive's IPO calendar's, the first trade the market data's, and the moves each stock's daily closes against its offer price.
The market cap is Breakaway's arithmetic: the shares the prospectus says will be outstanding after the offering, times the midpoint of the range or the offer price.
The Quality Score is Breakaway's, from a stock's second trading day; for its first 21 sessions it is marked New listing, and each check that needs more history waits for it.
Blank-check companies (SPACs) and unit offerings are left out and counted; a direct listing and a US listing of a company listed abroad are in and marked.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Every new listing, ranked live, free. No account.

See all 16 new listings ranked

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Every IPO expected and listed, and October 2025's listings.